Original Literature | Model OverView |
---|---|
Publication
Title
The actions of bacterial DNA on murine macrophages.
Affiliation
Centre for Molecular and Cellular Biology, and Department of Microbiology,University of Queensland, Australia.
Abstract
Murine macrophages are able to distinguish bacterial from mammalian DNA. Theresponse is mimicked by single-stranded oligonucleotides containing unmethylatedCG dinucleotides ("CpG" motifs) in specific sequence contexts. The dose-responsecurve for activation is influenced by variation in the sequence flanking thecore CpG motif. CpG or bacterial DNA activates several signaling pathways incommon with bacterial lipopolysaccharide (LPS), leading to induction of cytokinegenes such as tumor necrosis factor alpha. Pretreatment with LPS causesdesensitization to subsequent activation by CpG DNA. Both stimuli also causecell cycle arrest in macrophages proliferating in response to the macrophagegrowth factor colony-stimulating factor-1 (CSF-1), but prevent apoptosis causedby growth factor removal. In part, cell cycle arrest by CpG DNA and LPS may belinked to rapid down-modulation of the CSF-1 receptor from the cell surface, aresponse that occurs in an all-or-nothing manner. The response of macrophages toCpG DNA has aspects in common with the DNA damage response in other cell types,which may provide clues to the underlying mechanism.
PMID
10534106
|
Entity
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m17
10
infinite
0
TRANSPATH | MO000000058 |
--
TRAF6{active}
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
IRAK{active}
--
MO000000213
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m184
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000213 |
--
ERK1
--
MO000004670
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m549
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000004670 |
--
ERK2
--
MO000004676
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m554
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000004676 |
--
M-CSF-1-R
--
MO000007995
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1031
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000007995 |
--
MyD88{active}
--
MO000016573
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1572
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000016573 |
--
LPS
--
MO000016882
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m155666
10
infinite
0
TRANSPATH | MO000016882 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
IFNgamma:R
--
e11
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m11
0
infinite
0
--
CpGDNA
--
e12
cso30:c:Dna
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m12
0
infinite
0
--
CpG DNA receptor
--
e13
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m13
0
infinite
0
--
PAI-2
--
e14
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m14
0
infinite
0
--
csml-variable:Double
m15
0
infinite
0
--
Il-12
--
e16
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m16
0
infinite
0
--
LPS:TLR4
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m18
0
infinite
0
--
JNK
--
e18
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
p38
--
e19
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
NF-kappaB{active}
--
e20
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m21
10
infinite
0
TRANSPATH | MO000000058 |
--
ERK2{active}
--
e21
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m22
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000004676 |
--
ERK1{active}
--
e22
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m23
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000004670 |
--
p38{active}
--
e23
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
JNK{active}
--
e24
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
Ras
--
e28
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
M-CSF:M-CSF-1-R
--
e30
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m33
0
infinite
0
--
Ras{active}
--
e31
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m34
0
infinite
0
--
Ets2
--
e33
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
csml-variable:Double
m37
0
infinite
0
--
--
e35
cso30:c:EntityBiologicalCompartment
cso30:i:CC_GolgiTransFace
--
--
--
csml-variable:Double
m38
0
infinite
0
--
--
e36
cso30:c:EntityBiologicalCompartment
cso30:i:CC_GolgiMembrane
--
--
--
csml-variable:Double
m39
0
infinite
0
--
--
e37
cso30:c:EntityBiologicalCompartment
cso30:i:CC_GolgiApparatus
--
--
--
csml-variable:Double
m40
0
infinite
0
--
--
e38
cso30:c:EntityBiologicalCompartment
cso30:i:CC_GolgiLumen
--
--
--
csml-variable:Double
m41
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
M-CSF-1-R{p}
--
e40
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m43
0
infinite
0
--
IL-12:IL-12R
--
e5
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
IFNgammaR
--
e6
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c5 : 1
m15*m13*0.1
nodelay
--
0
PMID: 10534106 To activate cells, CpG DNA probably needs to be internalized via the endosomes. Although internalization of DNA appears to be essential for the biological response, the possibility that a co-stimulatory signal comes from a membrane receptor during the process of internalization should not be discounted.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c25 : 1
stoichiometry:c31 : 1
m1639*m6*0.1
nodelay
--
0
PMID: 10534106 Interferon-g in turn primes murine macrophages to respond to CpG DNA with expression of iNOS and nitric oxide production as well as increasing a number of other responses, creating a potential self-amplifying loop with NK cells PMID: 10534106, 1401905 Baccarini et al reported an increase in serine phosphorylation of the receptor in Bac1.2F5 cells treated with interferon-g plus LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m93479*0.1
nodelay
--
0
PMID: 10534106, 9568729, 8757335 In comparison to the response to LPS, CpG DNA was as effective at increasing TNF-a mRNA in bone marrow-derived murine macrophages, whereas it was a less effective inducer of IL-1b and plasminogen activator inhibitor type-2 and did not, by itself, lead to production of inducible nitric oxide synthase (iNOS) Interferon-g in turn primes murine macrophages to respond to CpG DNA with expression of iNOS and nitric oxide production as well as increasing a number of other responses, creating a potential self-amplifying loop with NK cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c33 : 1
stoichiometry:c34 : 1
m93323*m12*0.1
nodelay
--
0
PMID: 10534106, 9568729, 8757335 In comparison to the response to LPS, CpG DNA was as effective at increasing TNF-a mRNA in bone marrow-derived murine macrophages, whereas it was a less effective inducer of IL-1b and plasminogen activator inhibitor type-2 and did not, by itself, lead to production of inducible nitric oxide synthase (iNOS)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
stoichiometry:c37 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
p14
p14
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c65 : 1
stoichiometry:c52 : 1
m1572*m17*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m12*m19*0.1
nodelay
--
0
PMID: 10534106, 9799232, 9568729 The latter (MAP kinases) are also activated by CpG DNA in myeloid cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
stoichiometry:c46 : 1
m12*m20*0.1
nodelay
--
0
PMID: 10534106, 9799232, 9568729 The latter (MAP kinases) are also activated by CpG DNA in myeloid cells
p17
p17
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c40 : 1
stoichiometry:c39 : 1
m549*m12*0.1
nodelay
--
0
PMID: 10534106, 9799232, 9568729 The latter (MAP kinases) are also activated by CpG DNA in myeloid cells PMID: 10534106, 10586047 More recently, we confirmed that CpG DNA can mimic the ability of CSF-1 to activate phosphorylation of the MAP kinases ERK-1 and ERK-2 in macrophages
p17
p18
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c42 : 1
stoichiometry:c162 : 1
m12*m554*0.1
nodelay
--
0
PMID: 10534106, 9799232, 9568729 The latter (MAP kinases) are also activated by CpG DNA in myeloid cells PMID: 10534106, 10586047 More recently, we confirmed that CpG DNA can mimic the ability of CSF-1 to activate phosphorylation of the MAP kinases ERK-1 and ERK-2 in macrophages
p14
p19
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
stoichiometry:c66 : 1
stoichiometry:c55 : 1
m1572*m19*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c3 : 1
stoichiometry:c4 : 1
m12*0.1
nodelay
--
0
PMID: 10534106, 9568729, 8757335 In comparison to the response to LPS, CpG DNA was as effective at increasing TNF-a mRNA in bone marrow-derived murine macrophages, whereas it was a less effective inducer of IL-1b and plasminogen activator inhibitor type-2 and did not, by itself, lead to production of inducible nitric oxide synthase (iNOS)
p14
p20
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
stoichiometry:c67 : 1
stoichiometry:c58 : 1
m1572*m20*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
p14
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c60 : 1
stoichiometry:c68 : 1
stoichiometry:c61 : 1
m1572*m549*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
p14
p22
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
stoichiometry:c69 : 1
stoichiometry:c64 : 1
m1572*m554*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
p14
p23
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
stoichiometry:c73 : 1
stoichiometry:c72 : 1
m184*m17*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
p14
p24
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
stoichiometry:c77 : 1
stoichiometry:c76 : 1
m184*m19*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
p14
p25
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c81 : 1
stoichiometry:c80 : 1
m184*m20*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
p14
p26
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c83 : 1
stoichiometry:c85 : 1
stoichiometry:c84 : 1
m184*m549*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
p14
p27
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c89 : 1
stoichiometry:c88 : 1
m184*m554*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
p14
p28
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
stoichiometry:c93 : 1
stoichiometry:c92 : 1
m183*m17*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
p14
p29
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c95 : 1
stoichiometry:c97 : 1
stoichiometry:c96 : 1
m183*m19*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c7 : 1
stoichiometry:c8 : 1
m12*m16*0.1
nodelay
--
0
PMID: 10534106, 9245551, 10689778, 9464831 CpG DNA induces a range of cytokines in macrophages/ dendritic cells, including interleukin-12 (IL-12), tumor necrosis factor a (TNF-a), IL-1b, and IL-6.
p14
p30
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c101 : 1
stoichiometry:c100 : 1
m183*m20*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
p14
p31
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c103 : 1
stoichiometry:c105 : 1
stoichiometry:c104 : 1
m183*m549*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
p14
p32
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
stoichiometry:c109 : 1
stoichiometry:c108 : 1
m183*m554*0.1
nodelay
--
0
PMID: 10534106, 10334979 In the case of LPS signaling, it is now appreciated that such upstream activators include members of the IL-1 receptor signaling pathway, such as MyD88, IL-1 receptor-associated kinases (IRAK) and TRAF 6 PMID: 10534106, 10354505 LPS inhibits its own actions upstream of a branching point in the signaling cascade for activation of NF-kB and the MAP kinases (SAPK/JNK, p38, and ERK1/2).
p33
p33
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c129 : 1
stoichiometry:c130 : 1
stoichiometry:c133 : 1
m89*m1031*0.1
nodelay
--
0
PMID: 10534106, 9710599 We have demonstrated the constitutive activation of this pathway in response to CSF-1, and its role in phosphorylation of the transcription factor Ets2 PMID: 10534106 CSF-1 can activate Raf-1 in a ras-independent manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c114 : 1
1.0*0.1
nodelay
--
0
PMID: 10534106, 10354505, 6092475, 1401905, 2548952 LPS has been shown previously to cause rapid down-regulation of CSF-1 binding to murine macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c113 : 1
m95036*0.1
nodelay
--
0
PMID: 10534106, 10354505, 6092475, 1401905, 2548952 LPS has been shown previously to cause rapid down-regulation of CSF-1 binding to murine macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c111 : 1
stoichiometry:c43 : 1
stoichiometry:c112 : 1
1.0*0.1
nodelay
--
0
PMID: 10534106 Both LPS and bacterial DNA or CpG oligonucleotides cause rapid down-modulation of the CSF-1R from the cell surface. PMID: 10534106, 8497248 Indeed, down-modulation of the receptor from the cell surface is followed, at least in the case of LPS, by specific repression of c-fms (CSF-1R) mRNA transcription and RAW264 macrophage cells treated with LPS or CpG DNA for a prolonged period deplete both their cell surface and intracellular Golgi-associated pool of CSF-1R
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
m26*0.1
nodelay
--
0
PMID: 10534106 Both LPS and bacterial DNA or CpG oligonucleotides cause rapid down-modulation of the CSF-1R from the cell surface.
p38
p38
cso30:i:ME_UnknownActivation
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c137 : 1
stoichiometry:c119 : 1
m46*m155666*0.1
nodelay
--
0
--
p39
p39
cso30:i:ME_Internalization
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c122 : 1
stoichiometry:c121 : 1
m1031*m18*0.1
nodelay
--
0
PMID: 10534106 The biological importance of the specific internalization of the CSF-1R in response to CpG DNA and LPS is not known.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c9 : 1
stoichiometry:c11 : 1
stoichiometry:c10 : 1
m93309*m12*0.1
nodelay
--
0
PMID: 10534106, 9245551, 10689778, 9464831 CpG DNA induces a range of cytokines in macrophages/ dendritic cells, including interleukin-12 (IL-12), tumor necrosis factor a (TNF-a), IL-1b, and IL-6.
p39
p40
cso30:i:ME_Internalization
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c123 : 1
stoichiometry:c124 : 1
stoichiometry:c125 : 1
m12*m1031*0.1
nodelay
--
0
PMID: 10534106 The biological importance of the specific internalization of the CSF-1R in response to CpG DNA and LPS is not known.
p41
p41
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c126 : 1
stoichiometry:c127 : 1
stoichiometry:c128 : 1
m18*m28*0.1
nodelay
--
0
PMID: 10534106, 7799956 More recently the same group claimed that activation of Raf in LPS-stimulated cells was ras-independent
p42
p42
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c143 : 1
stoichiometry:c132 : 1
m31*m33*0.1
nodelay
--
0
PMID: 10534106 CSF-1 can activate Raf-1 in a ras-independent manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c135 : 1
stoichiometry:c136 : 1
m33*m30*0.1
nodelay
--
0
PMID: 10534106, 9710599 We have demonstrated the constitutive activation of this pathway in response to CSF-1, and its role in phosphorylation of the transcription factor Ets2
p44
p44
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c140 : 1
stoichiometry:c139 : 1
m47*m155666*0.1
nodelay
--
0
--
p45
p45
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c163 : 1
stoichiometry:c142 : 1
m48*m155666*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c144 : 1
stoichiometry:c145 : 1
stoichiometry:c146 : 1
m33*m36*0.1
nodelay
--
0
PMID: 10534106, 9710599 We have demonstrated the constitutive activation of this pathway in response to CSF-1, and its role in phosphorylation of the transcription factor Ets2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c148 : 1
m26*0.1
nodelay
--
0
PMID: 10534106 Both LPS and bacterial DNA or CpG oligonucleotides cause rapid down-modulation of the CSF-1R from the cell surface. PMID: 10534106, 8497248 Indeed, down-modulation of the receptor from the cell surface is followed, at least in the case of LPS, by specific repression of c-fms (CSF-1R) mRNA transcription and RAW264 macrophage cells treated with LPS or CpG DNA for a prolonged period deplete both their cell surface and intracellular Golgi-associated pool of CSF-1R
p48
p48
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c151 : 1
stoichiometry:c152 : 1
stoichiometry:c150 : 1
m1031*m18*m11*0.1
nodelay
--
0
PMID: 10534106, 1401905 Baccarini et al reported an increase in serine phosphorylation of the receptor in Bac1.2F5 cells treated with interferon-g plus LPS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c154 : 1
stoichiometry:c155 : 1
m27*m30*0.1
nodelay
--
0
PMID:10534106 One possibility is that after internalization the receptor provides a CSF-1-independent signal to the ras-raf-MAP kinase pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c14 : 1
stoichiometry:c13 : 1
m93364*m12*0.1
nodelay
--
0
PMID: 10534106, 9245551, 10689778, 9464831 CpG DNA induces a range of cytokines in macrophages/ dendritic cells, including interleukin-12 (IL-12), tumor necrosis factor a (TNF-a), IL-1b, and IL-6.
p49
p50
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c156 : 1
stoichiometry:c157 : 1
stoichiometry:c158 : 1
m34*m28*0.1
nodelay
--
0
PMID:10534106 One possibility is that after internalization the receptor provides a CSF-1-independent signal to the ras-raf-MAP kinase pathway.
p49
p51
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c159 : 1
stoichiometry:c160 : 1
stoichiometry:c161 : 1
m29*m69*0.1
nodelay
--
0
PMID:10534106 One possibility is that after internalization the receptor provides a CSF-1-independent signal to the ras-raf-MAP kinase pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c17 : 1
m12*m93248*0.1
nodelay
--
0
PMID: 10534106, 9245551, 10689778, 9464831 CpG DNA induces a range of cytokines in macrophages/ dendritic cells, including interleukin-12 (IL-12), tumor necrosis factor a (TNF-a), IL-1b, and IL-6.
p7
p7
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c19 : 1
stoichiometry:c20 : 1
m12340*m2121*0.1
nodelay
--
0
PMID: 10534106, 9245551, 8648098 In mixed spleen cell culture, CpG DNA-induced macrophage IL-12 promotes interferon-g production by NK cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c22 : 1
stoichiometry:c23 : 1
m5*m93423*0.1
nodelay
--
0
PMID: 10534106, 9245551, 8648098 In mixed spleen cell culture, CpG DNA-induced macrophage IL-12 promotes interferon-g production by NK cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m11*m12*0.1
nodelay
--
0
PMID: 10534106, 9568729, 8757335 In comparison to the response to LPS, CpG DNA was as effective at increasing TNF-a mRNA in bone marrow-derived murine macrophages, whereas it was a less effective inducer of IL-1b and plasminogen activator inhibitor type-2 and did not, by itself, lead to production of inducible nitric oxide synthase (iNOS) Interferon-g in turn primes murine macrophages to respond to CpG DNA with expression of iNOS and nitric oxide production as well as increasing a number of other responses, creating a potential self-amplifying loop with NK cells
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--